Literature DB >> 24655813

Cognitive dysfunction after chemotherapy for breast cancer.

Kim Edelstein1, Lori J Bernstein1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24655813     DOI： 10.1017/S1355617714000149

Source DB:  PubMed          Journal:  J Int Neuropsychol Soc        ISSN： 1355-6177            Impact factor:   2.892


× No keyword cloud information.
  8 in total

Review 1.  Cognitive functioning in thyroid cancer survivors: a systematic review and meta-analysis.

Authors:  Omar Saeed; Lori J Bernstein; Rouhi Fazelzad; Mary Samuels; Lynn A Burmeister; Lehana Thabane; Shereen Ezzat; David P Goldstein; Jennifer Jones; Anna M Sawka
Journal:  J Cancer Surviv       Date:  2019-04-04       Impact factor: 4.442

2.  A brief psychoeducational intervention improves memory contentment in breast cancer survivors with cognitive concerns: results of a single-arm prospective study.

Authors:  Lori J Bernstein; Graham A McCreath; Joyce Nyhof-Young; Dilan Dissanayake; Jill B Rich
Journal:  Support Care Cancer       Date:  2018-03-10       Impact factor: 3.603

Review 3.  Chemobrain in Breast Cancer: Mechanisms, Clinical Manifestations, and Potential Interventions.

Authors:  Giovana R Onzi; Nathalia D'Agustini; Solange C Garcia; Silvia S Guterres; Paula R Pohlmann; Daniela D Rosa; Adriana R Pohlmann
Journal:  Drug Saf       Date:  2022-05-23       Impact factor: 5.606

4.  Modulation of Interhemispheric Functional Coordination in Breast Cancer Patients Receiving Chemotherapy.

Authors:  Longxiang Tao; Lu Wang; Xingui Chen; Fujun Liu; Feiyan Ruan; Jingjie Zhang; Li Shen; Yongqiang Yu
Journal:  Front Psychol       Date:  2020-07-29

5.  Illness intrusiveness and subjective well-being in patients with glioblastoma.

Authors:  Kim Edelstein; Linda Coate; Christine Massey; Natalie C Jewitt; Warren P Mason; Gerald M Devins
Journal:  J Neurooncol       Date:  2015-09-29       Impact factor: 4.130

6.  The dorsolateral prefrontal cortex is selectively involved in chemotherapy-related cognitive impairment in breast cancer patients with different hormone receptor expression.

Authors:  Haijun Chen; Ke Ding; Jingjing Zhao; Herta H Chao; Chiang-Shan R Li; Huaidong Cheng
Journal:  Am J Cancer Res       Date:  2019-08-01       Impact factor: 6.166

7.  Association of Neurocognitive Deficits With Radiotherapy or Chemoradiotherapy for Patients With Head and Neck Cancer.

Authors:  Alona Zer; Gregory R Pond; Albiruni R Abdul Razak; Kattleya Tirona; Hui K Gan; Eric X Chen; Brian O'Sullivan; John Waldron; David P Goldstein; Ilan Weinreb; Andrew J Hope; John J Kim; Kelvin K W Chan; Andrew K Chan; Lillian L Siu; Lori J Bernstein
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2018-01-01       Impact factor: 6.223

8.  Diminished gray matter density mediates chemotherapy dosage-related cognitive impairment in breast cancer patients.

Authors:  Xiu Li; Haijun Chen; Yue Lv; Herta H Chao; Liang Gong; Chiang-Shan R Li; Huaidong Cheng
Journal:  Sci Rep       Date:  2018-09-14       Impact factor: 4.379
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.